divalproex sodium

Generic: divalproex sodium

Labeler: ncs healthcare of ky, llc dba vangard labs
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name divalproex sodium
Generic Name divalproex sodium
Labeler ncs healthcare of ky, llc dba vangard labs
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

divalproex sodium 250 mg/1

Manufacturer
NCS HealthCare of KY, LLC dba Vangard Labs

Identifiers & Regulatory

Product NDC 0615-8376
Product ID 0615-8376_efe6fc7b-e709-4f0d-ba7f-ffb7a87ad155
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209286
Listing Expiration 2026-12-31
Marketing Start 2020-09-18

Pharmacologic Class

Classes
anti-epileptic agent [epc] decreased central nervous system disorganized electrical activity [pe] mood stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 06158376
Hyphenated Format 0615-8376

Supplemental Identifiers

RxCUI
1099563 1099569
UNII
644VL95AO6

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name divalproex sodium (source: ndc)
Generic Name divalproex sodium (source: ndc)
Application Number ANDA209286 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8376-39)
source: ndc

Packages (1)

0615-8376-39 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8376-39)

Ingredients (1)

divalproex sodium (250 mg/1)

Linked Drug Pages (1)

Divalproex sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "efe6fc7b-e709-4f0d-ba7f-ffb7a87ad155", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099563", "1099569"], "spl_set_id": ["319bbead-bec8-4bb7-9ecb-b2e161c44b8d"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8376-39)", "package_ndc": "0615-8376-39", "marketing_start_date": "20210111"}], "brand_name": "Divalproex sodium", "product_id": "0615-8376_efe6fc7b-e709-4f0d-ba7f-ffb7a87ad155", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0615-8376", "generic_name": "Divalproex sodium", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "250 mg/1"}], "application_number": "ANDA209286", "marketing_category": "ANDA", "marketing_start_date": "20200918", "listing_expiration_date": "20261231"}